Botryomycosis in a child with acquired immunodeficiency syndrome.
Gavin
P J
PJ
Division of Infectious Diseases, Childrens' Memorial Hospital and Northwestern University Medical School, Chicago, IL, USA.
Das
L
L
Chadwick
E G
EG
Yogev
R
R
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000627:therapeutic use; D002506:Cephalexin / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008198:Lymph Nodes / Q000382:microbiology / Q000473:pathology; D010336:Pathology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification / Q000472:pathogenicity; D016896:Treatment Outcome
D000904:Antibiotics, Antitubercular; D002511:Cephalosporins; D002506:Cephalexin; D012293:Rifampin